1410 related articles for article (PubMed ID: 33571463)
1. Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines.
Moghimi SM
Mol Ther; 2021 Mar; 29(3):898-900. PubMed ID: 33571463
[No Abstract] [Full Text] [Related]
2. Safety of New mRNA Vaccines Against COVID-19 in Severely Allergic Patients.
Rojas-Pérez-Ezquerra P; Crespo Quirós J; Tornero Molina P; Baeza Ochoa de Ocáriz ML; Zubeldia Ortuño JM
J Investig Allergol Clin Immunol; 2021 Apr; 31(2):180-181. PubMed ID: 33648905
[No Abstract] [Full Text] [Related]
3. Delving Into COVID-19 Vaccination-Induced Anaphylaxis: Are mRNA Vaccines Safe in Mast Cell Disorders?
Azenha Rama T; Álvarez-Twose I
J Investig Allergol Clin Immunol; 2021 Apr; 31(2):193-195. PubMed ID: 33574015
[No Abstract] [Full Text] [Related]
4. Potential culprits for immediate hypersensitivity reactions to BNT162b2 mRNA COVID-19 vaccine: not just PEG.
Radice A; Fassio F; Meucci E; Iorno MCL; Macchia D
Eur Ann Allergy Clin Immunol; 2021 Sep; 53(5):240-242. PubMed ID: 33913314
[No Abstract] [Full Text] [Related]
5. The role and impact of polyethylene glycol on anaphylactic reactions to COVID-19 nano-vaccines.
Bigini P; Gobbi M; Bonati M; Clavenna A; Zucchetti M; Garattini S; Pasut G
Nat Nanotechnol; 2021 Nov; 16(11):1169-1171. PubMed ID: 34732846
[No Abstract] [Full Text] [Related]
6. Vaccination hesitancy and the "myth" on mRNA-based vaccines in Italy in the COVID-19 era: Does urgency meet major safety criteria?
Chirumbolo S
J Med Virol; 2021 Jul; 93(7):4049-4053. PubMed ID: 33666240
[TBL] [Abstract][Full Text] [Related]
7. Pfizer's vaccine raises allergy concerns.
de Vrieze J
Science; 2021 Jan; 371(6524):10-11. PubMed ID: 33384356
[No Abstract] [Full Text] [Related]
8. The Century of mRNA Vaccines: COVID-19 Vaccines and Allergy.
Ortega Rodríguez NR; Audícana Berasategui MT; de la Hoz Caballer B; Valero Santiago A
J Investig Allergol Clin Immunol; 2021 Feb; 31(1):89-91. PubMed ID: 33393485
[No Abstract] [Full Text] [Related]
9. How COVID unlocked the power of RNA vaccines.
Dolgin E
Nature; 2021 Jan; 589(7841):189-191. PubMed ID: 33437061
[No Abstract] [Full Text] [Related]
10. Nucleoside-modified messenger RNA COVID-19 vaccine platform.
Roncati L; Corsi L
J Med Virol; 2021 Jul; 93(7):4054-4057. PubMed ID: 33675239
[TBL] [Abstract][Full Text] [Related]
11. [COVID-19 vaccines increase the risk of anaphylaxis].
Alnæs M; Storaas T; Sørensen M; Stylianou E; Tøndell A
Tidsskr Nor Laegeforen; 2021 Mar; 141(4):. PubMed ID: 33685103
[No Abstract] [Full Text] [Related]
12. Anaphylaxis to the first COVID-19 vaccine: is polyethylene glycol (PEG) the culprit?
Garvey LH; Nasser S
Br J Anaesth; 2021 Mar; 126(3):e106-e108. PubMed ID: 33386124
[No Abstract] [Full Text] [Related]
13. Anaphylaxis associated with the mRNA COVID-19 vaccines: Approach to allergy investigation.
Erdeljic Turk V
Clin Immunol; 2021 Jun; 227():108748. PubMed ID: 33932618
[TBL] [Abstract][Full Text] [Related]
14. Insights from American College of Allergy, Asthma, and Immunology COVID-19 Vaccine Task Force: Allergic Reactions to mRNA SARS-CoV-2 Vaccines.
Murphy KR; Patel NC; Ein D; Hudelson M; Kodoth S; Marshall GD; Parikh P; Blaiss MS
Ann Allergy Asthma Immunol; 2021 Apr; 126(4):319-320. PubMed ID: 33493641
[No Abstract] [Full Text] [Related]
15. Vaccine allergy: evidence to consider for COVID-19 vaccines.
Nilsson L; Csuth Á; Storsaeter J; Garvey LH; Jenmalm MC
Curr Opin Allergy Clin Immunol; 2021 Aug; 21(4):401-409. PubMed ID: 34091550
[TBL] [Abstract][Full Text] [Related]
16. Maintaining Safety with SARS-CoV-2 Vaccines.
Castells MC; Phillips EJ
N Engl J Med; 2021 Feb; 384(7):643-649. PubMed ID: 33378605
[No Abstract] [Full Text] [Related]
17. COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocol.
Patel GB; Chhiba KD; Chen MM; Guo A; Watts MM; Cullen J; Bochner BS; Grammer LC; Greenberger PA; Saltoun CA; Stevens WW; Kuang FL; Peters AT
Allergy Asthma Proc; 2021 Nov; 42(6):515-521. PubMed ID: 34871159
[No Abstract] [Full Text] [Related]
18. COVID-19 mRNA vaccine-related adenopathy mimicking metastatic melanoma.
Prieto PA; Mannava K; Sahasrabudhe DM
Lancet Oncol; 2021 Jun; 22(6):e281. PubMed ID: 34087152
[No Abstract] [Full Text] [Related]
19. Excipients as Potential Agents of Anaphylaxis in Vaccines: Analyzing the Formulations of Currently Authorized COVID-19 Vaccines.
Caballero ML; Quirce S
J Investig Allergol Clin Immunol; 2021 Feb; 31(1):92-93. PubMed ID: 33433387
[No Abstract] [Full Text] [Related]
20. Allergy to COVID-19 vaccines: A current update.
Cabanillas B; Novak N
Allergol Int; 2021 Jul; 70(3):313-318. PubMed ID: 33962863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
